NIC
TXG icon

Northwest Investment Counselors’s 10x Genomics TXG Stock Holding History

Northwest Investment Counselors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$135 Buy
+6
New +$124 ﹤0.01% 618
2024
Q2 		– Sell
-6
Closed -$225 – 473
2024
Q1 		$225 Buy
+6
New +$264 ﹤0.01% 520
2023
Q4 		– Sell
-6
Closed -$248 – 504
2023
Q3 		$248 Buy
+6
New +$312 ﹤0.01% 561

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Northwest Investment Counselors's TXG Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in 10x Genomics (TXG) in Q3 2024: 6 shares worth $135. The stake represents ﹤0.01% of the portfolio and ranks #618 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in TXG as recently as Q1 2024.

Northwest Investment Counselors first reported a position in TXG in Q3 2023 and has held it in 3 quarters since. The position peaked at $248 in Q3 2023. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

  • Northwest Investment Counselors held 6 shares of 10x Genomics worth $135 as of Q3 2024.
  • 10x Genomics was a new Northwest Investment Counselors position in Q3 2024.
  • 10x Genomics made up ﹤0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #618 holding.
  • Northwest Investment Counselors first reported a position in 10x Genomics in Q3 2023 and has held it in 3 quarters since.
  • Northwest Investment Counselors's 10x Genomics position peaked at $248 in Q3 2023.
  • 266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.